Case Study: “Ventria Bioscience and the Controversy over Plant - Made Medicines” GB590 Corporate Social Responsibility Prof. Timothy Loney By Willette Marchany Rivera February 22‚ 2011 Introduction: Case overview Ventria Bioscience‚ a biotechnology firm based in California‚ faces the challenge of commercializing a product with potential and considerable public health benefits. Ventria had developed a ground-breaking technology using genetically modified (GM) rice to grow the proteins lactoferrin
Premium Agriculture Rice Ventria Bioscience
Case #4 Ventria Bioscience and the Controversy over Plant-Made Medicines Sinforosa Business and Society - BUS 475 Professor Filomena May 17‚ 2011 1.-Describe the problem facing Scott Deeter and Ventria. Deeter came to Ventria in April 2002. He was appointed as Ventria’s CEO because of his good reputation as a businessman. As CEO he helped Dr. Raymond Rodriguez sort through several projects that Ventria was working on at the time. His concept of the business was
Premium Management Marketing Risk
Ventria Bioscience | MGT 493 | Kimberly Stevens | In the 1980s Dr. Raymond Rodriguez‚ a molecular biologist on the faculty of the University of California – Davis‚ and his graduate students embarked on an ambitious research program aimed at improving the productivity of rice. He began to develop techniques to “express” medically useful proteins in rice plants‚ which could be extracted and purified. This technology later became known as “ExpressTec. Ventria Bioscience‚ originally called Applied
Premium Rice
Ventria Bioscience and the Controversy over Plant-Made Medicines In this paper I am writing on the Ventria Bioscience and the Controversy over Plant-Made Medicines Case. Ventria Bioscience is a company that is trying to commercialize pharmaceuticals made from genetically modified plants. While Ventria is gaining opposition from regulators‚ activist‚ and environmentalist; they could succeed if they use their relevant stakeholders and specific strategies‚ information‚ financial incentive‚ constituency
Premium Rice Genetically modified organism Genetic engineering
Ventria bioscience and the controversy over plant-made medicine 1. The problem facing Scott Deeter and his company Ventria is that CRC advisory board and California Secretary of Agriculture is not being convinced to allow Ventria start planting genetically modified Rice in California. Even though Deeter and his staff offered numerous concessions to address the concerns of rice farmers and other parties involved‚ but they still could not get an approval for their project. Deeter and his company
Premium DNA Genetically modified organism Genetically modified food
have with a degree in bioscience. Catastrophic pollution has damaged ecosystems worldwide for hundreds of years. Having a degree in bioscience and understanding what is happening while an individual is fishing can be both therapeutic and educational. Being able to understand that pollution doesn’t necessarily have to be toxic fluid or garbage. Any foreign object that is introduced until environment that was not previously there can be pollution. This is why I believe bioscience is both beneficial not
Premium Ocean Life Oceanography
January 30‚ 2017‚ between the hours of 1140 - 1230 in the Bioscience building on Northern Arizona University campus. There was students in class in room 256‚ BIO 223- Vertebrate Zoology and traffic of students coming in and out of the building. I observed approximately 80 students mostly white student and very few minorities. The minorities students that I observed during the first part of my observation were just passing through the Bioscience headed to Liberal Arts building and a majority of those
Premium Observation Scientific method Knowledge
and Ventria was denied the request to plant rice om a commercial scale‚ Deeter was facing the challenge to find the best way the inexperienced‚ high risk‚ investor supported company was going to meet their mission statement of being able to provide affordable human health products for the global community. In addition the company faced ongoing protest from various groups including environmentalist‚ food safety activist‚ consumer activist‚ and rice farmers. The original stake holder in Ventria was
Premium Genetically modified organism Genetically modified food Monsanto
The development of medicine has seen substantial progress in its lifetime; from primitive bleeding techniques to the treatment of cancers with chemotherapy. In the early 1800s‚ the world of medicine was introduced to anesthetics‚ followed by the invention of syringes‚ and the development of the first vaccines. The 1900s introduced a plethora of medical inventions and discoveries. The electrocardiograph was invented‚ insulin for diabetic patients‚ penicillin‚ cardiac pacemakers‚ and even the first
Premium Cancer Oncology Breast cancer
Experiment 2: Estimation of protein concentration Name: Wong Jiun Hao ID: 00000011136 Cohort: BM114 Module: Biological Science Table of Contents Title 1 Table of Contents 2 Introduction 3 Objectives 4 Procedure 4 Results 5-6 Discussion 7-8 Conclusion 9 References 9 Introduction The concentration of protein in a sample can be obtained by using the Bradford protein assay method. The method requires a spectrophotometer
Premium